337 related articles for article (PubMed ID: 21923922)
1. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
2. Targeted expression of activated Rac3 in mammary epithelium leads to defective postlactational involution and benign mammary gland lesions.
Leung K; Nagy A; Gonzalez-Gomez I; Groffen J; Heisterkamp N; Kaartinen V
Cells Tissues Organs; 2003; 175(2):72-83. PubMed ID: 14605486
[TBL] [Abstract][Full Text] [Related]
3. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
Castro NE; Lange CA
Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
[TBL] [Abstract][Full Text] [Related]
4. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
[TBL] [Abstract][Full Text] [Related]
6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
7. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.
Bianco C; Strizzi L; Mancino M; Watanabe K; Gonzales M; Hamada S; Raafat A; Sahlah L; Chang C; Sotgia F; Normanno N; Lisanti M; Salomon DS
Am J Pathol; 2008 Feb; 172(2):345-57. PubMed ID: 18202186
[TBL] [Abstract][Full Text] [Related]
9. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
Galliher AJ; Schiemann WP
Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
[TBL] [Abstract][Full Text] [Related]
10. Brk is coamplified with ErbB2 to promote proliferation in breast cancer.
Xiang B; Chatti K; Qiu H; Lakshmi B; Krasnitz A; Hicks J; Yu M; Miller WT; Muthuswamy SK
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12463-8. PubMed ID: 18719096
[TBL] [Abstract][Full Text] [Related]
11. Brk/PTK6 signaling in normal and cancer cell models.
Ostrander JH; Daniel AR; Lange CA
Curr Opin Pharmacol; 2010 Dec; 10(6):662-9. PubMed ID: 20832360
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
Weaver AM; Silva CM
Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
[TBL] [Abstract][Full Text] [Related]
13. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
[TBL] [Abstract][Full Text] [Related]
14. Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3.
Zhao L; Melenhorst JJ; Hennighausen L
Mol Endocrinol; 2002 Dec; 16(12):2902-12. PubMed ID: 12456808
[TBL] [Abstract][Full Text] [Related]
15. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.
Ikeda O; Sekine Y; Mizushima A; Nakasuji M; Miyasaka Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
J Biol Chem; 2010 Dec; 285(49):38093-103. PubMed ID: 20929863
[TBL] [Abstract][Full Text] [Related]
16. Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.
di Bari MG; Ginsburg E; Plant J; Strizzi L; Salomon DS; Vonderhaar BK
J Cell Physiol; 2009 Jun; 219(3):659-66. PubMed ID: 19170109
[TBL] [Abstract][Full Text] [Related]
17. Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling.
Quaglino A; Schere-Levy C; Romorini L; Meiss RP; Kordon EC
Breast Cancer Res; 2007; 9(5):R69. PubMed ID: 17925034
[TBL] [Abstract][Full Text] [Related]
18. Singleminded-2s (Sim2s) promotes delayed involution of the mouse mammary gland through suppression of Stat3 and NFκB.
Scribner KC; Wellberg EA; Metz RP; Porter WW
Mol Endocrinol; 2011 Apr; 25(4):635-44. PubMed ID: 21292822
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
20. Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase.
Munarini N; Jäger R; Abderhalden S; Zuercher G; Rohrbach V; Loercher S; Pfanner-Meyer B; Andres AC; Ziemiecki A
J Cell Sci; 2002 Jan; 115(Pt 1):25-37. PubMed ID: 11801721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
